DOTA-[Tyr3]-Octreotide
产品货号: KS042011
序列:DOTA-fCYwKTCT-ol (trifluoroacetate salt) (Cys2 and 7 bridge)
纯度:≥95%
分子式:C<sub>65</sub>H<sub>90</sub>N<sub>14</sub>O<sub>19</sub>S<sub>2</sub>
分子量:1421.64
外观:冻干粉末
CAS#:177943-89-4
储存条件:Store at -20°C or -80°C
所属分类:
产品中心
产品描述
描述:
应用 :
参考文献:
- 内容
-
- 商品名称: DOTA-[Tyr3]-Octreotide
- 产品货号: KS042011
- 序列: DOTA-fCYwKTCT-ol (trifluoroacetate salt) (Cys2 and 7 bridge)
- 纯度: ≥95%
- 分子式: C<sub>65</sub>H<sub>90</sub>N<sub>14</sub>O<sub>19</sub>S<sub>2</sub>
- 分子量: 1421.64
- 外观: 冻干粉末
- CAS#: 177943-89-4
- 储存条件: Store at -20°C or -80°C
DOTA-conjugated somatostatin analog for labeling with radiometals such as gallium-67 or gallium-68, indium-111, and yttrium-90. DOTA-TATE is a useful tool in receptor-mediated tumor imaging and peptide receptor-targeted radionuclide therapy. 序列: DOTA-DPhe-Cys-Tyr-DTrp-Lys-Thr-Cys-Thr-ol (trifluoroacetate salt)(Cys2 and 7 bridge) 单字母序列: DOTA-fCYwKTCT-ol (C2&C7 bridge) 参考文献: L.Kolby et al., Br. J. Cancer, 93, 1144 (2005) R.Valkema et al., J. Nucl. Med., 46, 83S (2005) M.de Jong et al., J. Nucl. Med., 46, 13S (2005) W.A.Breeman et al., Eur. J. Nucl. Med. Mol. Imaging, 30, 917 (2003) A.Capello et al., Cancer Biother. Radiopharm., 18, 761 (2003) Chinol, M. et al. Semin. Nucl. Med. 32,141(2002) De Jong, M. et al. Semin Nucl. Med. 32,133(2002)
关键词:
肽类药物,创新药物,肽类种子库
获取报价